NCT00433147View on ClinicalTrials.gov

A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 23, 2007

Primary Completion Date

February 19, 2008

Study Completion Date

February 19, 2008

Conditions
Gaucher Disease, Type 1Type 1 Gaucher DiseaseGaucher Disease
Interventions
DRUG

Afegostat tartrate

Trial Locations (10)

10016

New York

15213

Pittsburgh

19104

Philadelphia

30033

Decatur

33065

Coral Springs

45229

Cincinnati

52242

Iowa City

77030

Houston

94143

San Francisco

97239

Portland

Sponsors
All Listed Sponsors
lead

Amicus Therapeutics

INDUSTRY